Project to focus on improving access to EstroGel.
LifeMD, Inc. revealed in a company press release that is has agreed to terms on a partnership with Ascend Therapeutics, a subsidiary of Besins Healthcare and a specialty pharmaceutical company concentrating on women's health. As per the deal, the collaboration aims to provide integrated telehealth services to improve access to EstroGel 0.06% (estradiol gel), with LifeMD’s telehealth services now available on Ascend’s website.
“This agreement with Ascend Therapeutics, a global market leader improving women’s lives with a focus on innovative hormone therapies, is an example of an increasing number of pharmaceutical partnerships applying LifeMD technology and aptitude in consumer healthcare engagement,” said Justin Schreiber, chairman, CEO, LifeMD. “By providing patient access to a high-quality physician at the moment they are searching for treatment, we are removing barriers to care – like lengthy appointment wait times and risk of inconsistent care by less experienced practitioners – while also improving health outcomes by providing on-demand and ongoing access to primary care providers.”
Reference: LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy. LifeMD. September 21, 2023. Accessed September 22, 2023. https://ir.lifemd.com/press-release-details.php#/?newsId=2747072
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.